ARTICLE | Finance
Flagship's enterprise
Early stage investor Flagship pulls in $270M for biotech platform plays
January 16, 2012 8:00 AM UTC
Investors bought into Flagship Ventures' plan to hunt for early stage platform plays, contributing an oversubscribed $270 million to Flagship Ventures Fund IV.
The initial target was $250 million...